Streetbeat News

Price Targets

IIPR

Piper Sandler analyst Alexander Goldfarb maintains a Neutral rating on Innovative Industrial Properties (NYSE:IIPR) and raises the price target from $80 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:35 pm

PTLO

Piper Sandler analyst Nicole Miller Regan has maintained an Overweight rating on Portillos (NASDAQ:PTLO), but lowered the price target from $23 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:34 pm

ECPG

JMP Securities analyst David Scharf maintains a Market Outperform rating on Encore Capital Gr (NASDAQ:ECPG) but lowers the price target from $61 to $56.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:33 pm

WING

Piper Sandler analyst Nicole Miller Regan maintains a Neutral rating on Wingstop (NASDAQ:WING) and raises the price target from $177 to $191.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:31 pm

TAP

Wedbush analyst Gerald Pascarelli has reiterated a Neutral rating on Molson Coors Beverage (NYSE:TAP) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:30 pm

CDXS

Piper Sandler analyst Kashy Harrison maintains an Overweight rating on Codexis (NASDAQ:CDXS) but has lowered the price target from $14 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:28 pm

SBUX

Wedbush analyst Nick Setyan has maintained a Neutral rating on Starbucks (NASDAQ:SBUX) and raised the price target from $100 to $106.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:28 pm

CBAY

Piper Sandler analyst Yasmeen Rahimi maintains an Overweight rating on CymaBay Therapeutics (NASDAQ:CBAY) and raises the price target from $19 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:26 pm

MLTX

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on MoonLake (NASDAQ:MLTX) and maintained a price target of $86.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:25 pm

ZTS

Piper Sandler analyst David Westenberg maintains an Overweight rating on Zoetis (NYSE:ZTS) and raises the price target from $210 to $215.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:24 pm